Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor

被引:8
作者
Gardner, JD
Sloan, S
Robinson, M
Miner Jr, PB
机构
[1] Sci Org Inc, Chatham, NJ 07928 USA
[2] Janssen Pharmaceut Inc, Titusville, NJ USA
[3] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Fdn Digest Res, Oklahoma City, OK USA
关键词
D O I
10.1111/j.1365-2036.2004.02279.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: We are unaware of any solid theoretical or pathophysiological basis for selecting pH 4 or any other pH value to assess gastric acidity. Aim: To examine the frequency of different gastric pH values in control and GERD subjects. Methods: Gastric pH was measured for 24 h in 26 control subjects, 26 gastro-oesophageal reflux disease subjects at baseline and the same 26 gastro-oesophageal reflux disease subjects during treatment with a proton-pump inhibitor. Histograms were constructed using the 21 600 values generated from each recording and bins of 0.25 pH units. Results: The distribution of gastric pH values in gastro-oesophageal reflux disease subjects was significantly different from that in controls and in some instances the distributions detected significant differences that were not detected by integrated acidity. Proton-pump inhibitor treatment significantly altered the distribution of gastric pH values and the nature of this alteration during the postprandial period was different from that during the nocturnal period. Using time pHless than or equal to4 can significantly underestimate the magnitude of inhibition of gastric acidity caused by a proton-pump inhibitor. Conclusions: The distribution of gastric pH values provides a rationale for selecting a particular pH value to assess gastric acidity. In some instances, the distribution of gastric pH values detects significant differences between gastro-oesophageal reflux disease and normal subjects that are not detected by integrated acidity.
引用
收藏
页码:1381 / 1386
页数:6
相关论文
共 16 条
[1]   Time to maximum effect of lansoprazole on gastric pH in normal male volunteers [J].
Bell, NJV ;
Hunt, RH .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (06) :897-904
[2]   APPROPRIATE ACID SUPPRESSION FOR THE MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE [J].
BELL, NJV ;
BURGET, D ;
HOWDEN, CW ;
WILKINSON, J ;
HUNT, RH .
DIGESTION, 1992, 51 :59-67
[3]  
DESVARANNES SB, 1994, ALIMENT PHARM THERAP, V8, P309
[4]   Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal [J].
Fletcher, J ;
Wirz, A ;
Young, J ;
Vallance, R ;
McColl, KEL .
GASTROENTEROLOGY, 2001, 121 (04) :775-783
[5]   The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis [J].
Gardner, JD ;
Gallo-Torres, H ;
Sloan, S ;
Robinson, M ;
Miner, PB .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (09) :891-905
[6]   Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor [J].
Gardner, JD ;
Sloan, S ;
Miner, PB ;
Robinson, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (07) :955-964
[7]   Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease [J].
Gardner, JD ;
Sloan, S ;
Miner, PB ;
Robinson, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (07) :945-953
[8]   Integrated acidity and rabeprazole pharmacology [J].
Gardner, JD ;
Perdomo, C ;
Sloan, S ;
Hahne, WF ;
Barth, JA ;
Rodriguez-Stanley, S ;
Robinson, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (03) :455-464
[9]  
Gardner JD, 2001, AM J GASTROENTEROL, V96, P1363
[10]  
GARDNER JD, IN PRESS ALIMENT PHA